We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

31 hedge funds and large institutions have $9.97M invested in Achieve Life Sciences in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,829% more call options, than puts

Call options by funds: $205K | Put options by funds: $7K

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

0.68% more ownership

Funds ownership: 20.43% → 21.11% (+0.68%)

6% less funds holding

Funds holding: 33 → 31 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

32% less capital invested

Capital invested by funds: $14.6M → $9.97M (-$4.66M)

Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
9
Closed
9
Calls
$205K
Puts
$7K
Net Calls
+$198K
Net Calls Change
-$400K

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$810K
2
LFCM
Long Focus Capital Management
Puerto Rico
+$798K
3
PCM
Perkins Capital Management
Minnesota
+$363K
4
DC
Diametric Capital
Massachusetts
+$132K
5
Group One Trading
Group One Trading
Illinois
+$112K

Top Sellers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
-$924K
2
DAM
DLD Asset Management
New York
-$345K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$259K
4
PVI
Pura Vida Investments
New York
-$131K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$95K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$12K -$26.8K -3,949 -61%
Osaic Holdings
27
Osaic Holdings
Arizona
$12K +$6.11K +900 +55%
Simplex Trading
28
Simplex Trading
Illinois
$10K -$69.4K -10,238 -82%
UBS Group
29
UBS Group
Switzerland
$5K +$7.3K +1,077 New
NFSG
30
Newbridge Financial Services Group
Florida
$2K – – –
AWM
31
Avior Wealth Management
Nebraska
$2K +$3.26K +480 New
ACM
32
Altium Capital Management
New York
– -$924K -122,000 Closed
DAM
33
DLD Asset Management
New York
– -$345K -45,528 Closed
PVI
34
Pura Vida Investments
New York
– -$131K -17,325 Closed
Two Sigma Advisers
35
Two Sigma Advisers
New York
– -$95K -12,485 Closed
TPA
36
Trivium Point Advisory
Connecticut
– -$92K -11,750 Closed
OQS
37
Occudo Quantitative Strategies
Florida
– -$83K -11,001 Closed
Charles Schwab
38
Charles Schwab
California
– -$79K -10,306 Closed
SSA
39
Schonfeld Strategic Advisors
New York
– -$77K -10,200 Closed
GGI
40
Godsey & Gibb Inc
Virginia
– -$3K -453 Closed
1
2

ACHV Hedge Fund Activity: Q2 2022 in Review

31 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2022, worth a combined $9.97M — down 32% from $14.6M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ACHV and 7 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 11 added.

The largest buyer was Wells Fargo, adding an estimated $810K. The largest seller was Altium Capital Management, exiting entirely with an estimated $924K sold.

  • 31 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2022, down from 33 in Q1 2022.
  • Funds reported $9.97M of Achieve Life Sciences stock for Q2 2022, down 32% quarter-over-quarter.
  • 7 funds opened new Achieve Life Sciences positions in Q2 2022 and 9 closed out, a net change of -2 holders.
  • The largest Achieve Life Sciences buyer in Q2 2022 was Wells Fargo, an estimated $810K added.
  • The largest Achieve Life Sciences seller in Q2 2022 was Altium Capital Management, an estimated $924K sold.

Based on aggregated 13F filings for Q2 2022.